Previous studies have revealed that NF-κB, PI3K and MAPK signaling pathways were involved in the regulation of CRC via PD-L1 by resveratrol, piceatannol and panaxadiol (22, 220). The gene discussed is NFKB1; the disease is colorectal carcinoma.